Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
One in eight American adults is taking GLP-1s. What does that mean for how we relate to our food, bodies and one another?
Digital pathology and artificial intelligence are transforming the drug development landscape, accelerating the path to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results